SOMATROGON-GHLA for Dwarfism: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 110 adverse event reports in the FDA FAERS database where SOMATROGON-GHLA was used for Dwarfism.
Most Reported Side Effects for SOMATROGON-GHLA
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Injection site pain | 738 | 69.8% | 0 | 2 |
| Wrong technique in device usage process | 43 | 4.1% | 0 | 0 |
| Injection site erythema | 42 | 4.0% | 0 | 0 |
| Incorrect dose administered by device | 41 | 3.9% | 0 | 0 |
| Injection site swelling | 38 | 3.6% | 0 | 0 |
| Off label use | 29 | 2.7% | 0 | 3 |
| Patient-device incompatibility | 29 | 2.7% | 0 | 0 |
| Headache | 27 | 2.6% | 0 | 3 |
| Needle issue | 27 | 2.6% | 0 | 0 |
| Device mechanical issue | 24 | 2.3% | 0 | 0 |
| Device delivery system issue | 23 | 2.2% | 0 | 0 |
| Incorrect dose administered | 22 | 2.1% | 0 | 0 |
| Drug dose omission by device | 21 | 2.0% | 0 | 0 |
| Injection site mass | 21 | 2.0% | 0 | 0 |
| Device leakage | 19 | 1.8% | 0 | 0 |
Other Indications for SOMATROGON-GHLA
Growth hormone deficiency (373)
Hypopituitarism (38)
Short stature (31)
Blood growth hormone (5)
Blood growth hormone decreased (5)